British Journal of Clinical Pharmacology

Thrombolysis for stroke: pushed out of the window?
pp. 681-682(2)

Genes, disease and medicine
pp. 683-695(13)
Author: DYKES, COLIN W.

Pharmacokinetics of inhaled drugs
pp. 697-705(9)
Author: LIPWORTH, BRIAN J.

Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans
pp. 707-711(5)
Authors: BÖTTIGER, Y.; DOSTERT, P.; STROLIN BENEDETTI, M.; BANI, M.; FIORENTINI, F.; CASATI, M.; POGGESTI, I.; ALM, C.; ALVAN, G.; BERTILSSON, L.

A novel mutant variant of the CYP2D6 gene (CYP2D6 17) common in a black African population: association with diminished debrisoquine hydroxylase activity
pp. 713-719(7)
Authors: MASIMIREMBWA, COLLEN; PERSSON, IRENE; BERTILSSON, LEIF; HASLER, JULIA; INGELMAN-SUNDBERG, MAGNUS

Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: Interaction with low dose acetylsalicylic acid
pp. 721-727(7)
Authors: BÖGER, RAINER H.; BODE-BÖGER, STEFANIE M.; KRAMME, PETRA; TSIKAS, DIMITRIOS; GUTZKI, FRANK-M.; FRÖLICH, JÜRGEN C.

Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosine
pp. 729-735(7)
Authors: GLEITER, C. H.; FREUDENTHALER, S.; DELABAR, U.; ECKARDT, K. U.; MÜHLBAUER, B.; GUNDERT-REMY, U.; OSSWALD, H.

A method for simultaneous determination of plasma and erythrocyte antioxidant status. Evaluation of the antioxidant activity of vitamin E in healthy volunteers
pp. 737-741(5)
Authors: ABELLA, ANNIE; MESSAOUDI, CHERIF; LAURENT, DENIS; MAROT, DIDIER; CHALAS, JACQUELINE; BREUX, JOCELYNE; CLAISE, CATHERINE; LINDENBAUM, ALBERT

Effect of food on the absorption of frusemide and bumetanide in man
pp. 743-746(4)
Authors: McCRINDLE, J. L.; LI KAM WA, T. C.; BARRON, W.; PRESCOTT, L. F.

Characterization and validation of a pharmacokinetic model for controlled-release oxycodone
pp. 747-756(10)
Authors: MANDEMA, JAAP W.; KAIKO, ROBERT F.; OSHLACK, BENJAMIN; REDER, ROBERT F.; STANSKI, DONALD R.

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal
pp. 757-763(7)
Authors: PRICE, JOHN S.; WALLER, PATRICK C.; WOOD, SUSAN M.; MACKAY, ANGUS V. P.

Clinical drug monitoring by microdialysis: application to levodopa therapy in Parkinson's disease
pp. 765-769(5)
Authors: O'CONNELL, MARK T.; TISON, FRANÇOIS; QUINN, NIALL P.; PATSALOS, PHILIP N.

Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population
pp. 771-773(3)
Authors: BASCI, N. E.; BOZKURT, A.; KORTUNAY, S.; ISIMER, A.; SAYAL, A.; KAYAALP, S. O.

Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo
pp. 774-778(5)
Authors: TASSANEEYAKUL, WICHITTRA; BIRKETT, DONALD J.; PASS, MICHAEL C.; MINERS, JOHN O.

Pharmacokinetics of the individual enantiomers of vigabatrin in neonates with uncontrolled seizures
pp. 779-781(3)
Authors: VAUZELLE-KERVROËDAN, F.; REY, E.; PONS, G.; d'ATHIS, Ph.; CHIRON, C.; DULAC, O.; DUMAS, C.; OLIVE, G.

Effects of picotamide, an antiplatelet agent, on cardiovascular events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study
pp. 782-785(4)
Authors: MILANI, MASSIMO; LONGONI, ALDO; MADERNA, MICHELA

Improved tolerability of ritonavir derived from pharmacokinetic principles
pp. 787-787(1)